These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5920793)

  • 21. A new differentiation antigen of plasma cells.
    Takahashi T; Old LJ; Hsu CJ; Boyse EA
    Eur J Immunol; 1971 Dec; 1(6):478-82. PubMed ID: 4947913
    [No Abstract]   [Full Text] [Related]  

  • 22. [Functional activity of the lymphocytes of mouse lymph nodes in a system of viral carcinogenesis].
    Umanskiĭ IuA; Evsev'eva AI; Semenova-Kobzar' RA; Kushko LIa
    Tsitologiia; 1979 Feb; 21(2):191-5. PubMed ID: 432958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant changes in New Zealand black mice.
    East J; De Sousa MA; Prosser PR; Jaquet H
    Clin Exp Immunol; 1967 Jul; 2(4):427-43. PubMed ID: 4167748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.
    Tigelaar RE; Feldmann M
    Transplant Proc; 1973 Dec; 5(4):1711-5. PubMed ID: 4272825
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the effect of specific antisera on the metabolism of cellular antigens. I. Isolation of thymus leukemia antigens.
    Yu A; Cohen EP
    J Immunol; 1974 Apr; 112(4):1285-95. PubMed ID: 4815091
    [No Abstract]   [Full Text] [Related]  

  • 26. Mouse thymic iso-antigens.
    Reif AE; Allen JM
    Nature; 1966 Jan; 209(5022):521-3. PubMed ID: 5919593
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody.
    Lamm ME; Boyse EA; Old LJ; Lisowska-Bernstein B; Stockert E
    J Immunol; 1968 Jul; 101(1):99-103. PubMed ID: 4173941
    [No Abstract]   [Full Text] [Related]  

  • 28. Adoptive transfer of tumour homograft immunity by lymph node cells undergoing graft-versus-host reaction.
    Medzihradský J; Klobusická M; Koníková E; Babusíková O
    Neoplasma; 1971; 18(3):233-40. PubMed ID: 4398444
    [No Abstract]   [Full Text] [Related]  

  • 29. [Importance of specific and nonspecific immunity in anti-tumor defense].
    Biozzi G; Stiffel C; Mouton D; Bouthillier Y; Decreusefond C
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):685-94. PubMed ID: 5050875
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experiments for the demonstration of the Graffi leukemia virus in tissues of infected animals of various species].
    Micheel B; Pasternak G
    Arch Geschwulstforsch; 1968; 31(2):123-32. PubMed ID: 4299996
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of specific antigen in tissues of mice with leukemia induced by Mazurenko virus using the in vitro cytotoxic reaction.
    Zueva YN
    Fed Proc Transl Suppl; 1965; 24(6):1070-2. PubMed ID: 4284851
    [No Abstract]   [Full Text] [Related]  

  • 32. Localization of mouse isoantigens on the cell surface as revealed by immunofluorescence.
    Cerottini JC; Brunner KT
    Immunology; 1967 Oct; 13(4):395-403. PubMed ID: 4168095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous release of cytotoxic alloantibody from viable cells sensitized in excess antibody.
    Chang S; Stockert E; Boyse EA; Hämmerling U; Old LJ
    Immunology; 1971 Nov; 21(5):829-38. PubMed ID: 4940171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [RESULTS OF ORGAN-TYPE CULTURE IN VITRO OF MOUSE LYMPHOID LEUKEMIA].
    POURREAU-SCHNEIDER N
    C R Hebd Seances Acad Sci; 1964 Apr; 258():3939-41. PubMed ID: 14145410
    [No Abstract]   [Full Text] [Related]  

  • 35. [Specific surface leukemic antigen and malignization of cells in mice of CC57BR strain innoculated with Mazurenko virus].
    Gurtsevich VE; Mazurenko NP; Zharova EI; Probatova NA; Stepanova GN
    Biull Eksp Biol Med; 1970 Mar; 69(3):100-4. PubMed ID: 4323986
    [No Abstract]   [Full Text] [Related]  

  • 36. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 37. Availability of isoantigens to circulating antibodies.
    Witz I; Yagi Y; Pressman D
    J Immunol; 1968 Aug; 101(2):217-23. PubMed ID: 5691257
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocyte population of AKR-J mice. II. Effect of leukemogenesis on migration patterns, response to PHA, and expression of theta antigen.
    Zatz MM; White A; Goldstein AL
    J Immunol; 1973 Nov; 111(5):1519-25. PubMed ID: 4744927
    [No Abstract]   [Full Text] [Related]  

  • 39. Biological and morphological studies of SJL-J strain reticulum cell neoplasms induced and transmitted serially in low-leukemia-strain mice.
    Fujinaga S; Poel WE; Williams WC; Dmochowski L
    Cancer Res; 1970 Mar; 30(3):729-42. PubMed ID: 4316600
    [No Abstract]   [Full Text] [Related]  

  • 40. [Morphological studies in syngenic tumor-carriers after splenectomy].
    Zarudin VV; Shcherbakov VIa
    Arkh Patol; 1974; 36(4):56-61. PubMed ID: 4457085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.